\
&
Contact us
\
&
Contact us
This was 7 months ago
LocationThe Tides office
There is 1 attachment connected to this article.
Attachments are only accessible for people with an account on the NCP Flanders website.
The Polish Presidency of the Council of the EU organises a conference called EU Innovation Journey '25 on the 12th-13th of May 2025 in Warsaw, Poland.
This conference will bring together key actors from across the European innovation ecosystem to co-develop recommendations on how to bridge the innovation gap in Europe. The conference will focus on the CEE region and widening countries.
More information and registration: here.
Please find a draft version of the agenda in attachment.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
